As a quintessential New Yorker might say, there’s a storm brewing in the financial district. The big shots are lining up to file crypto ETFs, just as Gary Gensler, the head honcho at the SEC, is packing his bags. Financial titans like Tidal Financial Group, ProShares, CoinShares and VanEck are jumping in, sensing the winds […]
Therapeutic mainstays like oncology and neuroscience have hogged the spotlight lately. With flashy billion-dollar acquisitions and groundbreaking drugs for diseases like Alzheimer’s and various cancers, who could look away? Big players like Johnson & Johnson haven’t been shy, forking over a hefty sum of $14.6 billion for neuropsychiatric leader Intra-Cellular Therapies. But wait, 2025 might […]